[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 139 Introduced in Senate (IS)]

114th CONGRESS
  1st Session
                                 S. 139

   To permanently allow an exclusion under the Supplemental Security 
 Income program and the Medicaid program for compensation provided to 
  individuals who participate in clinical trials for rare diseases or 
                              conditions.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            January 8, 2015

     Mr. Wyden (for himself, Mr. Hatch, Mr. Markey, and Mr. Brown) 
introduced the following bill; which was read twice and referred to the 
                          Committee on Finance

_______________________________________________________________________

                                 A BILL


 
   To permanently allow an exclusion under the Supplemental Security 
 Income program and the Medicaid program for compensation provided to 
  individuals who participate in clinical trials for rare diseases or 
                              conditions.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ensuring Access to Clinical Trials 
Act of 2015''.

SEC. 2. ELIMINATION OF SUNSET PROVISION.

    Effective as if included in the enactment of the Improving Access 
to Clinical Trials Act of 2009 (Public Law 111-255, 124 Stat. 2640), 
section 3 of that Act is amended by striking subsection (e).
                                 <all>